Company / Inventory per Share
Acadia Pharmaceuticals Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.67
FY2025
5-year range
$0.07 / $0.67
FY2021-FY2025
Trend
+20.0%
vs FY2024
Sector context
#46 of 105
Health Care
What the data says
At $0.67, Acadia Pharmaceuticals's inventory per share ranks #46 of 105 in the Health Care sector. Inventory per Share has increased for 3 consecutive years, from $0.07 in FY2022 to $0.67 in FY2025.
Based on SEC 10-K filings.
0.67 in FY2025 with a 5-year CAGR of +60.7%.
Improved from $0.25 to $0.67 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +110.3%
- 5-Year CAGR
- +60.7%
- 10-Year CAGR
- -
Sector benchmark
#46 of 105 in Health CareTop 44% of 105This company $0.67 Sector average $30.82
▼
-97.8% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's inventory per share has grown for 3 consecutive years.
- In FY2025, inventory per share increased 20.0% year-over-year.
- Ranks #46 out of 105 companies in the Health Care sector.
- Lowest inventory per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.67 | +20.0% |
| FY2024 | $0.56 | +123.1% |
| FY2023 | $0.25 | +247.6% |
| FY2022 | $0.07 | -18.7% |
| FY2021 | $0.09 | +41.6% |
| FY2020 | $0.06 | +41.5% |
| FY2019 | $0.04 | +34.7% |
| FY2018 | $0.03 | -24.3% |
| FY2017 | $0.04 | +5.6% |
| FY2016 | $0.04 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026